Paper4875696
Effect of neuraminidase on the phagocytosis of heterologous red cells by mouse peritoneal macrophages.
Lee A. Proc Soc Exp Biol Med, 1968. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effect of neuraminidase on the phagocytosis of heterologous red cells by mouse peritoneal macrophages. Papers, record 4875696. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4875696
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of neuraminidase on the phagocytosis of heterologous red cells by mouse peritoneal macrophages.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythrocytes | Major topic |
| Macrophages | Major topic |
| Neuraminidase | Major topic |
| Phagocytosis | Major topic |
| Animals | |
| Male | |
| Methods | |
| Mice | |
| Microscopy, Phase-Contrast | |
| Opsonin Proteins |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 5042921 | The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity. | Clin Exp Immunol | 1972 | https://conductscience.org/library/papers/5042921 | PubMed |
| 4562008 | Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells. | Ann Surg | 1972 | https://conductscience.org/library/papers/4562008 | PubMed |
| 4007714 | Phagocytosis of protamine-heparin aggregates by mouse peritoneal exudate cells. | Folia Microbiol (Praha) | 1985 | https://conductscience.org/library/papers/4007714 | PubMed |
| 846180 | Neuraminidase and tumor immunotherapy. | Klin Wochenschr | 1977 | https://conductscience.org/library/papers/846180 | PubMed |
| 346477 | Effect of Vibrio cholerae neuraminidase on the phagocytosis of E. coli by macrophages in vivo and in vitro. | Immunology | 1978 | https://conductscience.org/library/papers/346477 | PubMed |
| 342397 | Stimulatory effect of Vibrio cholerae neuraminidase on the antibody response to various antigens. | Immunology | 1978 | https://conductscience.org/library/papers/342397 | PubMed |
| 278997 | Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytes. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/278997 | PubMed |
| 57881 | The role of sialic acid in determining the life-span of circulating cells and glycoproteins. | Experientia | 1976 | https://conductscience.org/library/papers/57881 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4875696
GET https://conductscience.org/api/papers/v1/4875696/authors